Description

Will AI cure all disease? 90% of biomedical papers published in December 2025 show signs of AI assistance — and the Nobel laureate behind AlphaFold says AI could help end all disease within a decade. In this episode, Robert Lufkin MD examines what artificial intelligence is really doing to health science: the quiet takeover of the scientific paper, the first AI-discovered drug to pass a Phase 2a trial, robot laboratories running experiments around the clock, and the honest caveats behind the "end of disease" headlines — plus what it all means for your health today.

Chapters:

• 00:00 — The 90% Stat: AI Fingerprints in Biomedical Papers
• 00:49 — Part 1: The Quiet Takeover of the Scientific Paper
• 02:16 — Part 2: The Wins Are Real
• 02:46 — AlphaFold, 200 Million Proteins & the 2024 Nobel Prize
• 03:13 — Rentosertib: First AI-Discovered Drug to Pass Phase 2a
• 04:02 — The Superbug Puzzle: 10 Years vs 2 Days
• 04:22 — Part 3: Robot Labs & the 10-Year Promise
• 05:26 — Demis Hassabis on "The End of Disease"
• 06:26 — Part 4: The New Bottleneck Is Verification
• 07:43 — Part 5: The Honest Caveats
• 08:42 — Part 6: The Takeaway

Key takeaways:

• Roughly 90% of biomedical papers published in December 2025 show measurable signs of AI writing assistance — most of it polishing, not fraud.
• AlphaFold predicted structures for essentially all 200 million known proteins and earned the 2024 Nobel Prize in Chemistry.
• Rentosertib became the first drug with an AI-discovered target and AI-designed molecule to improve lung function in a randomized, placebo-controlled Phase 2a trial (Nature Medicine).
• Autonomous "robot labs" like Lila Sciences ($1.3B valuation, backed by Nvidia) aim to run science at machine speed.
• The bottleneck in science is shifting from producing findings to verifying them — zero AI-discovered drugs have full FDA approval so far.
• No matter how fast discovery gets, your metabolic health remains the foundation AI can't replace.

Studies & sources:

• Kobak et al. — Detecting AI fingerprints in biomedical abstracts (preprint)
• Nature News — AI-written biomedical literature
• Nobel Prize in Chemistry 2024 — AlphaFold
• Rentosertib Phase 2a randomized trial, Nature Medicine 2025
• BBC News — Imperial College superbug question answered by AI in 2 days
• Fierce Biotech — Lila Sciences autonomous AI research labs
• Lila Sciences — $1.3B valuation with Nvidia backing
• CBS 60 Minutes — Demis Hassabis on "the end of disease"

📖 Dr. Lufkin's book "Lies I Taught in Medical School"

⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!

New episodes every other Tuesday. Subscribe so you don't miss one.

Continue this conversation on Substack: https://robertlufkinmd.substack.com

Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/

Web: https://www.robertlufkinmd.com
YouTube: https://www.youtube.com/robertlufkinmd
X: https://x.com/robertlufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/